Jim Cramer Blog

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.

Black & Decker (NYSE:BDK) & Onyx Pharmaceuticals (NasdaqGM:ONXX). BDK's PowerRating is 6, and ONXX's PowerRating is 8.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
International Paper (NYSE:IP) & Archstone-Smith (NYSE:ASN). IP's PowerRating is 6, and ASN's PowerRating is7.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Gymboree (NasdaqGS:GYMB) & Penn National Gaming (NasdaqGS:PENN). GYMB's PowerRating is 8, and PENN's PowerRating is 8.
Bearish
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Citizens Republic Bancorp (NasdaqGS:CRBC). CRBC's PowerRating is 4.
PowerRatings (for Traders) are courtesy of TradingMarkets.com

Labels: ASN, BDK, CRBC, GYMB, Hot Stocks, IP, ONXX, PENN

Celgene (NasdaqGS: CELG - News), Onyx Pharmaceuticals (NasdaqGM: ONXX - News): Although Celgene's stock performance has been like a "tree falling in the woods," Cramer would buy the stock because of Revlimid, its cancer drug. The stock is up 50% since last year and is "ready to roll again." He also likes ONXX which was ignored at American Society of Clinical Oncology conference, in spite of its liver cancer drug. Cramer says its decline is a "mistake."
Wal-Mart (NYSE: WMT - News): In spite of WMT's 3% gain for a second day, Cramer would not wait for it to decline, but believes the stock could reach $61 next year from $50.
Sirius Satellite Radio (NasdaqGS: SIRI - News): A Bear Stearns analyst's upgrade of SIRI was a "big call," and Cramer would consider buying the stock on the analyst's credibility. However, the call was "not working" with SIRI down 3 cents at $2.85, but he predicts SIRI will reach the estimate of $4.
Published by SeekingAlpha

Labels: CELG, Jim Cramer, ONXX, SIRI, Stop Trading, WMT

Here are 7 stocks for traders for Thursday from TradingMarkets.com:
Whole Foods (NasdaqGS:WFMI) missed earnings on Wednesday after the close; analysts were looking for $0.36 EPS, but the company only announced $0.32 EPS. WFMI's PowerRating is 4.
Onyx Pharmaceuticals (NasdaqGM:ONXX) beat earnings on Wednesday, with -$0.26 EPS over a consensus of -$0.43 EPS. ONXX's PowerRating is 4.
Biovail (NYSE:BVF) announces earnings on Thursday before the market opens; watch for $0.41 EPS. BVF's PowerRating is 6.
Consolidated Edison (NYSE:ED) is expected to announce $0.81 EPS on Thursday before the bell. ED's PowerRating is 5.
When Lamar Advertising (NasdaqGS:LAMR) announces earnings tomorrow morning, look for no EPS ($0.00). LAMR's PowerRating is 5.
Sara Lee (NYSE:SLE) should report $0.13 EPS when the company reports on Thursday morning. SLE's PowerRating is 5.
Analysts are watching for Urban Outfitters (NasdaqGS:URBN) to report $0.17 EPS tomorrow morning. URBN's PowerRating is 5.
PowerRatings are courtesy of PowerRatings.net

Labels: BVF, ED, Hot Stocks, LAMR, ONXX, SLE, URBN, WFMI

Bullish calls:Crocks (NasdaqGS: CROX): ' ... take advantage of the way the bears pushed down Crocs.'Under Armour (NYSE: UA - News) InterDigital (NasdaqGS: IDCC): 'I'm blessing. ... I think it's OK. It is at a 52-week high.'Yamana Gold (NYSE: AUY - News): '52-week high I am not backing down. We caught a double.'Texas Roadhouse (NasdaqGS: TXRH): 'JPMorgan stepped up to the plate today and they agree that Texas Roadhouse should no longer be the punching bag that it's been. ... It's going to 20.'Transocean (NYSE: RIG - News)Mastercard (NYSE: MA - News): 'People who sold MasterCard are going to be dead wrong. ... MasterCard at 107, two thumbs up, way up.'Halliburton (NYSE: HAL - News): 'What I am sticking with is, on the low valuation [Halliburton and Transocean.]'NYSE Group (NYSE: NYX - News): 'Indeed, my stock of the year. ... Indeed when that merger is done ... the Euronext deal ... the numbers will go up ... And I am proud to say that I backed up the truck when it went into the 80s. Did you?'Onyx Pharmaceuticals (NasdaqGM: ONXX): '... I think people feel Onyx Pharma has run too much. ... I think it can get a bid.'BEA Systems (NasdaqGS: BEAS)Devon Energy (NYSE: DVN - News)Marvell Technology (NasdaqGS: MRVL)
Bearish calls: Delia's (NasdaqGM: DLIA): 'Too Tough.'Goldcorp (NYSE: GG - News): 'I used to love GG, then they did that really bad merger.'Helix Energy (NYSE: HLX - News)New River Pharmaceuticals (NasdaqGM: NRPH)Chesapeake Energy (NYSE: CHK - News)

Published By SeekingAlpha

Labels: AUY, BEAS, CHK, DVN, GG, HAL, HLX, Jim Cramer, Lightning Round, MA, Mad Money, MRVL, NYX, ONXX, RIG, UA

Nabi Biopharmaceuticals (NasdaqGM:NABI - News) said Thomas McLain has resigned as chairman, chief executive and president, effective immediately. The company has appointed Leslie Hudson, a company director since 2005, as interim CEO and president for a six-month term.
Onyx Pharmaceuticals (NasdaqGM:ONXX - News) said its quarterly net loss narrowed to $20.7 million, or 47 cents a share, from $38.4 million, or $1 a share, in the same period during 2005, as expenses on research and development dropped considerably. Analysts polled by Thomson Financial had expected a per-share loss of 62 cents.
Perini Corp. (NYSE:PCR - News) shares advanced after the Framingham, Mass.-based construction services company reported fourth-quarter net earnings and earnings available to common shareholders of $19.3 million, or 72 cents a share. In the same quarter last year, Perini posted a net loss of $13.9 million, and a loss available to common shareholders of $11.7 million, or 45 cents a share. Revenue rose to $944.3 million from $603.2 million. Perini reaffirmed its 2007 earnings forecast of $2 to $2.20 a share on revenue of $3.8 billion to $4 billion.
Pogo Producing Co. (NYSE:PPP - News) swung to a fourth-quarter loss of $16.5 million, or 29 cents a share, from a profit of $114.7 million, or $1.96 a share, a year ago. The energy company said revenue fell 18% to $343.1 million from $419.6 million a year ago. The company also said it plans to explore its strategic options, including a possible sale or merger.
Radiant Systems' (NasdaqGM:RADS - News) shares leapt after the Atlanta-based technology services provider reported a fourth-quarter net profit of $3.59 million, or 11 cents a share, up from $2.43 million, or 8 cents a share, last year. Excluding items the company posted a per-share profit of $6.46 million, or 20 cents a share. Revenue rose to $60.8 million from $48.3 million. Analysts polled by Thomson Financial were expecting a per-share profit of 17 cents on revenue of $59.3 million. Radiant now expects first quarter adjusted earnings of 11 cents to 12 cents a share on revenue of $55 million to $56 million, and 2007 adjusted earnings of 64 cents to 67 cents a share on revenue of $245 million to $260 million.
Stamps.com (NasdaqGM:STMP - News) shares advanced after the Los Angeles-based company reported fourth-quarter net earnings of $4.68 million, or 20 cents a share, up from $4.1 million, or 17 cents a share, in the year-ago period. Excluding stock-based compensation expense, the quarterly profit in the 2006 fourth quarter came in at 22 cents a share. Revenue rose to $25 million from $20.6 million. Analysts polled by Thomson Financial were expecting a per-share profit of 20 cents on revenue of $24 million. Stamps.com forecast 2007 earnings of 70 to 80 cents a share, or 80 to 90 cents a share excluding items, on revenue of $90 million to $100 million.
Strayer Education (NasdaqGS:STRA - News) was upgraded to outperform at Robert Baird and to neutral at SunTrust Robinson Humphrey.
Terex (NYSE:TEX - News) was upgraded to buy from sell at Citigroup Investment Research. The firm also lifted its price target to $78 from $60.
United Stationers Inc. (NasdaqGS:USTR - News) reported fourth-quarter earnings of $33.6 million, or $1.10 per share, up from a year-ago profit of $23.5 million, or 72 cents a share. Sales rose 3.7% in the latest three months to $1.1 billion in the latest quarter. Looking ahead, the Deerfield, Ill., distributor of building products said sales year-to-date are trending up about 5.5% in 2006 versus last year.

Labels: NABI, ONXX, PCR, PPP, RADS, STMP, STRA, TEX, USTR

Labels: AGIX, BRCM, DO, GOOG, GPS, IYR, ONXX, stock options

The stock market traded cautiously today, ultimately declining on a lack of economic news and few high-profile merger announcements or other news to encourage buying. Quite the opposite occurred, with two potential deals collapsing over the weekend. Investors were also wary ahead of Congressional testimony from Federal Reserve Chairman Ben Bernanke on Wednesday, at which time he'll discuss the state of the economy. Oil prices retreated sharply, closing under $58 a barrel, while the 10-year Treasury note also fell, with the yield rising two basis points to 4.80%.
The most prominent deal to collapse was the second failed attempt by the NASDAQ Stock Market (Nasdaq: NDAQ - News) to acquire the London Stock Exchange. The LSE's shareholders overwhelmingly rejected NASDAQ's $5.3 billion merger offer on Saturday, agreeing with management that the offer undervalued the European exchange. NASDAQ's shares declined -6% in today's trading. Also falling apart were merger talks between French-based pharmaceutical Sanofi-Aventis (NYSE: SNY - News) and Bristol Myers-Squibb (NYSE: BMY - News), according to published reports in London over the weekend. That news sent the former slightly higher but the latter down -3%. Elsewhere, Canada-based aluminum producer Novelis (NYSE: NVL - News) added 13% after it agreed to be acquired by Indian metals producer Hindalco Industries for $3.6 billion. Four Seasons Hotels (NYSE: FS - News) slid -3% on news it would go private in a management-led buyout.
In business news, biotech Onyx Pharmaceuticals (Nasdaq: ONXX - News) skyrocketed after it reported a successful trial that extends the uses of its principal product. The California company's market value nearly doubled, gaining 97%, after it announced that its cancer treatment Nexavar "significantly" improved the survival rates of patients with advanced liver cancer. The Phase III trial was stopped early so that all patients in the trial could have access to the drug. Nexavar, jointly marketed with Bayer (NYSE: BAY - News), is presently only approved for the treatment of kidney cancer. Analysts speculated that Bayer might move to acquire Onyx based on the trial results.
Partly rebounding from recent selling was Apple (Nasdaq: AAPL - News). The stock's 2% climb today was fueled in part by an upgrade by Citigroup, which raised its rating on Apple to "buy" from "hold." Citigroup cited the expectation for significant new product releases from Apple as the basis for its recommendation. Citigroup's change is in contrast to that of Goldman Sachs, which removed Apple from its "Americas Conviction Buy List" last Thursday due to "negative speculation" in advance of Apple's launch of the iPhone.
Elsewhere, new Home Depot (NYSE: HD - News) CEO Frank Blake reversed a key strategic direction pursued by the company's former boss Robert Nardelli. The home repair retailer said it would examine strategic alternatives for its wholesale supply business. Under Nardelli, Home Depot expanded into the lower-margin wholesale business as part of a diversification plan. Large shareholders had long criticized the move as a distraction from Home Depot's core retail business. The stock finished up 1%.
By the BullMarket.com Staff

Labels: AAPL, BAY, BMY, FS, HD, NDAQ, NVL, ONXX, SNY

LCA-Vision Inc. (NasdaqGS:LCAV - News) reported fourth-quarter earnings of $7.1 million, or 34 cents a share, up from a year-ago profit of $6.6 million, or 30 cents a share. Revenue jumped 26% in the latest three months to $58.8 million from $46.8 million a year ago. The Cincinnati-based provider of laser vision correction services also said it's increased its quarterly dividend by 50% to 18 cents a share from 12 cents. Looking ahead, LCA-Vision forecast earnings of $2.05 to $2.15 a share for 2007 on revenue growth of 20% to 25%.
Lions Gate (NYSE:LGF - News) reported third-quarter net earnings of $20.5 million, or 17 cents a share, compared with $3.14 million, or 3 cents a share, in the same period last year, driven by revenue from the company's "Saw III" and "Employee of the Month" films.
Loews Corp. (NYSE:LTR - News) reported consolidated net income of $746.5 million, or $1.11 a share, for the fourth quarter, up from a year-ago equivalent profit of $127.6 million, or 8 cents a share. This performance includes contributions from both Loews Group and Carolina Group, whose net income rose to $137.1 million, or $1.26 per Carolina Group share, in the quarter, from $81.6 million, or $1.11 a share, a year earlier. On a continuing operations basis, Loews earned $633.4 million, or $1.15 per share, in the latest quarter. Loews attributed its higher earnings to improved results at CNA Financial , its 89%-owned subsidiary, and Diamond Offshore Drilling , its 54%-owned subsidiary.
Municipal Mortgage & Equity LLC (NYSE:MMA - News) said it knows of no reason why recent trading in the stock has resulted in a decrease in price. Since Monday, shares of the real estate debt and equity financing concern have dropped almost 15%. MuniMae management noted that it is not engaged in sub-prime or any other single family mortgage lending activities, and that its outlook for the multifamily rental sector is positive.
Novelis was in focus after the company agreed to be acquired by Hindalco Industries Ltd. in a deal worth $6 billion, including debt assumption. The consideration values Novelis at $44.93 a share.
OmniVision (NasdaqGS:OVTI - News) unveiled a 5.17 megapixel auto-focus camera module for mobile handsets based on its OV5623 CameraChip sensor. The company also unveiled its TrueFocus camera with Wavefront Coding technology for the mobile handset market.
Onyx Pharmaceuticals (NasdaqGM:ONXX - News) soared after the company and Bayer (NYSE:BAY - News) said a Phase 3 trial of Nexavar to treat advanced liver cancer was closed early due to a positive outcome. Bayer and Onyx will stop the trial and allow all patients enrolled in this trial access to Nexavar. Given that there are limited approved systemic therapies for this disease, the companies will continue discussions with health authorities worldwide, including the U.S. Food and Drug Administration and European health authorities regarding the next steps in filing for approval for the treatment in advanced liver cancer. Nexavar is currently approved in nearly 50 countries, including the United States and in the European Union, for the treatment of patients with advanced kidney cancer.
Shares of Panera Bread Co. (NasdaqGS:PNRA - News) edged higher after Raymond James upgraded the bakery-café chain to strong buy from outperform, citing valuation. The company reported Friday fourth-quarter earnings that rose over year-earlier levels but fell shy of expectations, according to Thomson Financial, and provided an outlook that was slightly below forecasts. Analyst Bryan Elliott noted that the stock traded up most of the day before turning lower at the close. "We believe that that this reflects intermediate and longer-term capital that has been on the sideline waiting for 2007 guidance to be released," Elliott said in a research note. "We believe there is sufficient interest from this class of investor to keep Panera Bread under accumulation for at least the next several months."
R.H. Donnelly (NYSE:RHD - News) was upgraded to overweight from neutral at J.P. Morgan.
Smithfield Foods (NYSE:SFD - News) was upgraded to outperform from market perform at Wachovia Securities. The firm cited expectations about the benefits of recent acquisitions.
Southwest Airlines (NYSE:LUV - News) was upgraded to outperform at Bear Stearns.
Triple Crown Media Inc. (NasdaqGM:TCMI - News) said it swung to a fiscal second-quarter net profit of $418,000, or 8 cents a share. The company, which owns and operates local newspapers and runs a collegiate marketing business offering sports marketing services, reported a loss of $802,000 or 16 cents a share in the year-earlier quarter. Revenue for the quarter jumped to $48.1 million from $12.3 million, driven by the acquisition of the marketing business from Bull Run Corp.
Vodafone Group (NYSE:VOD - News) agreed to acquire Hutchison Telecom's (NYSE:HTX - News) 67% stake in Indian mobile operator Hutchison Essar for $11.1 billion and the assumption of $2 billion in debt.
WCI Communities (NYSE:WCI - News) said it's retained Goldman Sachs to assist it in identifying ways to increase shareholder value. The Bonita Springs, Fla. homebuilder said that it expects to generate $1 billion in free cash flow in 2007, and will look at asset sales to help reduce debt. Once the balance sheet is improved, the company will review strategic alternatives, including possible share repurchases are a sale of the company.
Witness Systems' (NasdaqGS:WITS - News) shares rallied after the company agreed to be acquired by Verint Systems (Other OTC:VRNT.PK - News), a unit of Comverse Technology (Other OTC:CMVT.PK - News), for $27.50 a share, or roughly $950 million.
Zoltek Cos. (NasdaqGM:ZOLT - News) shares rose after the St. Louis-based materials reported a fiscal first-quarter net loss of $5.66 million, or 23 cents a share. The quarter included a charge of $8.4 million related to convertible debt and warrant issuances. In the same quarter last year, the company posted net earnings of $6.29 million, or 3 cents a share. Revenue rose to $30.3 million from $15.6 million.
Published By Michael Baron of MarketWatch

Labels: BAY, CMVT, HTX, LCAV, LGF, LTR, LUV, MMA, ONXX, OVTI, PNRA, RHD, SFD, TCMI, VOD, VRNT, WCI, WITS, ZOLT

Wall Street extended its losses Monday as investors awaited a stream of key economic data this week and were left disappointed by the collapse of several closely-watched acquisition deals.
The markets, which pulled back last week amid concern about inflation's impact on interest rates, traded cautiously with Federal Reserve Chairman Ben Bernanke set to speak before Congress on Wednesday. Government data due on Friday will shed new light on wholesale inflation and the state of the housing market.
Unlike recent Monday mornings, there was a dearth of acquisition announcements to give the market a lift. Instead, investors had to deal with news that the Nasdaq Stock Market Inc. failed in its bid to buy the London Stock Exchange and that French drugmaker Sanofi-Aventis called off talks for a possible deal with Bristol-Myers Squibb Co.
Onyx Pharmaceuticals Inc. and Bayer AG advanced after the companies released data from a clinical trial that shows an experimental drug is effective in fighting liver cancer. Apple Inc. moved higher after being upgraded in anticipation of big product launches set this year.
Wall Street fell last week on concerns about higher oil prices and the possibility inflation could lead to higher interest rates. With fourth-quarter earnings reports nearly over, investors have traded hesitantly as they wait for some kind of catalyst to give them direction
In midmorning trading, the Dow Jones industrial average fell 13.62, or 0.11 percent, to 12,567.21.
Broader stock indicators declined. The Standard & Poor's 500 index was down 2.93, or 0.20 percent, at 1,435.13 and the Nasdaq composite index retreated 8.62, or 0.35 percent, to 2,451.20.
Bonds edged lower ahead of economic data due out this week, with the yield on the benchmark 10-year Treasury note rising to 4.79 percent from 4.78 percent late Friday. The dollar was mixed against other major currencies, while gold prices dropped.
Oil, which advanced last week as cold weather was seen increasing heating demand, was down on the New York Mercantile Exchange. A barrel of light sweet crude fell $1.21 to $58.68.
Nasdaq, the world's largest electronic equities exchange, edged lower after LSE shareholders did not approve its bid to acquire the British bourse. Shares fell $1.82, or 4.9 percent, to $35.38. Bristol Myers tumbled $1.41, or 4.9 percent, to $27.11 after a report that Sanofi-Aventis called off deal talks amid a disagreement over price.
But aluminum producer Novelis Inc. rose $5.31, or 13.7 percent, to $43.85 after it agreed to be bought by India's Hindalco Industries Ltd.
Apple, which recently unveiled plans to roll out its long-anticipated iPhone, rose $1.06 to $84.33 after it was upgraded by a Citigroup analyst. Meanwhile, good news about a potential treatment for liver cancer sent Bayer up 17 cents to $58 and Onyx up $6.42, or 52.3 percent, to $18.68.
The Russell 2000 index of smaller companies was down 2.06, or 0.26 percent, at 805.05.
Overseas, Japan's markets were closed. In afternoon trading, Britain's FTSE 100 was down 0.31 percent, Germany's DAX index fell 0.54 percent, and France's CAC-40 was fell 0.62 percent.
Published by Joe Bel Bruno, AP Business Writer

Labels: AAPL, BAY, BMY, NDAQ, NVL, ONXX, SNY

Stocks are trading mixed Monday morning amid falling crude oil prices and another round of merger activity. Shortly after the opening bell on Wall Street, the Dow Jones Industrials ($INDU) was up 20 points on the session. The NASDAQ ($COMPQ) was trading modestly lower.Several deals were announced. India’s Hindalco is buying out Novelis (NVL) for approximately $6 billion. Shares of the aluminum company are up $5.40 to $43.94 on the news. Four Seasons Hotels (FS) is going private for $82 a share, or roughly $3.37 billion. Tenaris SA is making plans to buy Hydril (HYDL) at a 17% premium from last Friday’s closing price. The deal values the maker of steel valves and connectors at approximately $2.2 billion.
In other stock news, Apple Computer (AAPL) is trading higher after Citigroup raised the rating on the stock to “buy” from “hold.” Onyx Pharmaceuticals (ONXX) is rallying after the company said its Nexavar cancer drug, developed jointly with Bayer AG, helped patients with liver tumors live longer. Google (GOOG) is trading lower after a group of media companies accused the company of “benefiting from the sale of pirated movies and providing business support to two Web sites suspected of offering access to illegal film downloads,” according to Dow Jones Newswires, citing people familiar with the matter.
Crude oil prices are moving lower after reaching more than $60.00 a barrel last week. Crude was recently down 99 cents to $58.90 a barrel. Exxon Mobile (XOM), ConocoPhillips (COP) and other energy-related shares are trading lower as well. No economic data is due out today, but the calendar is busy later in the week. Retail sales and business inventories are due out Wednesday. Industrial Production and the Philadelphia Fed follow on Thursday. Friday holds key data on housing and inflation.
Traders will also be watching the tone of the market after the sell-off late last week. On Friday, volume rose to its best levels of the week as the Dow slid 57 points and the NASDAQ tumbled 28. It turned out to be the most volatile trading session of the week and now traders will want to see if the major averages will rebound from the one-day debacle as they have in the recent past or if selling pressure is beginning to build, which could set the table for a long awaited market pullback or correction.

Frederic Ruffy of Optionetics.com

Labels: AAPL, COP, FS, GOOG, HYDL, NVL, ONXX, XOM

Drug makers Bayer Pharmaceuticals Corp. and Onyx Pharmaceuticals Inc. said Monday that the addition of the drug Nexavar to chemotherapy failed to improve the survival of skin cancer patients.
Shares of Onyx fell $4.75, or 27.1 percent, to $12.75 in premarket activity on the INET electronic exchange after closing Friday at $17.50 on the Nasdaq. The stock has traded between $12.70 and $30.66 over the past 52 weeks.

Labels: BAY, Bayer Pharmaceuticals Corp., ONXX, Onyx Pharmaceuticals Inc.

Most Under Priced Calls: These are the most under priced calls of all stocks in our database. While the Equities Explosion List finds groups of calls for individual equities that are under priced, this list finds the most under priced individual calls. Thus, the options listed here will tend to be more severely under priced.
Wynn Resorts Ltd. (NASDAQ:WYNN - News) Jan 90.0. WYNN's PowerRating is 2.
Most Under Priced Puts: These are the most under priced puts of all stocks in our database. While the Equities Explosion List finds groups of puts for individual equities that are under priced, this list finds the most under priced individual puts. Thus, the options listed here will tend to be more severely under priced.
Sears Holdings (NASDAQ:SHLD - News) Jan 165.0. SHLD's PowerRating is 5.
Most Overpriced Calls: These are the most overpriced calls of all stocks in our database. While the Equities Implosion List finds groups of calls for individual equities that are overpriced, this list finds the most overpriced individual calls. Thus, the options listed here will tend to be more severely overpriced.
GoogleInc. (NASDAQ:GOOG - News) Jan 540.0. GOOG's PowerRating is 4.
Most Overpriced Puts: These are the most overpriced puts of all stocks in our database. While the Equities Implosion List finds groups of puts for individual equities that are overpriced, this list finds the most overpriced individual puts. Thus, the options listed here will tend to be more severely overpriced.
Research in Motion Ltd. (NASDAQ:RIMM - News) Jan 110.0. RIMM's PowerRating is 2.
Stocks with Abnormal Call Volume: These are stocks which showed unusual call option volume not easily explained by arbitrage operations. The appearance of a stock on the Call Volume Alerts list suggests a possible takeover, extraordinarily good earnings report, or other news which may favorably affect the stock.
None today.
Stocks with Abnormal Put Volume: These are stocks which showed unusual put option volume not easily explained by arbitrage operations. The appearance of a stock on the Put Volume Alerts list suggestsan extraordinarily negative earnings report, or other news which may negatively affect the stock.
ONYX Pharmaceuticals Inc. (NASDAQ:ONXX - News). ONXX's PowerRating is 5.
Abnormal Put/Call $ Volume: These stocks have the highest dollar put volume in relation to their call volume. These high ratios are indicative of extreme bearish sentiment in the underlying stock.
PfizerInc. (NYSE:PFE - News). PFE's PowerRating is 5.
PowerRatings are courtesy of PowerRatings.net

Labels: GOOG, Google, ONXX, ONYX Pharmaceuticals, pfe, Pfizer, Research in Motion Ltd., RIMM, Sears Holdings, SHLD, Wynn Resorts Ltd.